Crowe Colleen A, Mistry Chintan D, Rzechula Kathleen, Kulstad Christine E
Department of Emergency Medicine, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA.
Am J Emerg Med. 2010 Jul;28(6):689-93. doi: 10.1016/j.ajem.2009.03.007.
The study aimed to determine mortality in septic patients 2 years after introduction of a modified early goal-directed therapy (EGDT) protocol and to measure compliance with the protocol.
This was an observational study of prospectively identified patients treated with EGDT in our emergency department (ED) from May 2007 through May 2008 and compared with retrospectively obtained data on patients treated before protocol implementation, from May 2004 to May 2005.
This study was conducted at a large tertiary-care suburban community hospital with more than 85 000 ED visits annually and 700 inpatient beds.
Patients with severe sepsis or septic shock were included in the study.
A modified EGDT protocol was implemented.
A total of 216 patients were treated with our EGDT protocol, with 32.9% mortality (95% confidence interval [CI], 26.6%-39.2%); 183 patients (84.7%) had septic shock, with a mortality of 34.4% (95% CI, 28%-41%). Our control group of 205 patients had a 27.3% mortality (95% CI, 21.2%-33.5%), of which 123 had septic shock with a mortality of 43.1% (95% CI, 34%-52%). Early goal-directed therapy protocol compliance was as follows: 99% received adequate intravenous fluids, 99% had a central line, 98% had antibiotics in the first 6 hours, 28% had central oxygen saturation measured, 3.7% received dobutamine, and 19% were transfused blood.
Although we found a trend toward decreased mortality in patients with septic shock treated with EGDT, with an absolute difference of 8.7%, this difference was not statistically significant. Compliance with individual elements of the protocol was variable.
本研究旨在确定采用改良早期目标导向治疗(EGDT)方案两年后的脓毒症患者死亡率,并评估对该方案的依从性。
这是一项观察性研究,前瞻性纳入2007年5月至2008年5月在我院急诊科接受EGDT治疗的患者,并与2004年5月至2005年5月方案实施前回顾性收集的患者数据进行比较。
本研究在一家大型三级郊区社区医院进行,该医院每年急诊科就诊人数超过85000人,拥有700张住院床位。
纳入严重脓毒症或脓毒性休克患者。
实施改良的EGDT方案。
共有216例患者接受了我们的EGDT方案治疗,死亡率为32.9%(95%置信区间[CI],26.6%-39.2%);183例患者(84.7%)发生脓毒性休克,死亡率为34.4%(95%CI,28%-41%)。我们的205例对照组患者死亡率为27.3%(95%CI,21.2%-33.5%),其中123例发生脓毒性休克,死亡率为43.1%(95%CI,34%-52%)。早期目标导向治疗方案的依从性如下:99%接受了充足的静脉补液,99%置入了中心静脉导管,98%在最初6小时内使用了抗生素,28%测量了中心血氧饱和度,3.7%使用了多巴酚丁胺,19%接受了输血。
尽管我们发现接受EGDT治疗的脓毒性休克患者死亡率有下降趋势,绝对差异为8.7%,但该差异无统计学意义。对方案各个要素的依从性各不相同。